Correlation Between Fubon MSCI and GeneReach Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Fubon MSCI and GeneReach Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fubon MSCI and GeneReach Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fubon MSCI Taiwan and GeneReach Biotechnology, you can compare the effects of market volatilities on Fubon MSCI and GeneReach Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fubon MSCI with a short position of GeneReach Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fubon MSCI and GeneReach Biotechnology.

Diversification Opportunities for Fubon MSCI and GeneReach Biotechnology

-0.8
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Fubon and GeneReach is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding Fubon MSCI Taiwan and GeneReach Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GeneReach Biotechnology and Fubon MSCI is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fubon MSCI Taiwan are associated (or correlated) with GeneReach Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GeneReach Biotechnology has no effect on the direction of Fubon MSCI i.e., Fubon MSCI and GeneReach Biotechnology go up and down completely randomly.

Pair Corralation between Fubon MSCI and GeneReach Biotechnology

Assuming the 90 days trading horizon Fubon MSCI Taiwan is expected to generate 1.18 times more return on investment than GeneReach Biotechnology. However, Fubon MSCI is 1.18 times more volatile than GeneReach Biotechnology. It trades about -0.07 of its potential returns per unit of risk. GeneReach Biotechnology is currently generating about -0.1 per unit of risk. If you would invest  14,075  in Fubon MSCI Taiwan on August 30, 2024 and sell it today you would lose (260.00) from holding Fubon MSCI Taiwan or give up 1.85% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Fubon MSCI Taiwan  vs.  GeneReach Biotechnology

 Performance 
       Timeline  
Fubon MSCI Taiwan 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Fubon MSCI Taiwan are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Fubon MSCI is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
GeneReach Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GeneReach Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Fubon MSCI and GeneReach Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Fubon MSCI and GeneReach Biotechnology

The main advantage of trading using opposite Fubon MSCI and GeneReach Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fubon MSCI position performs unexpectedly, GeneReach Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeneReach Biotechnology will offset losses from the drop in GeneReach Biotechnology's long position.
The idea behind Fubon MSCI Taiwan and GeneReach Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites